Cite
HARVARD Citation
Drusbosky, L. et al. (2020). Complete response to avelumab and IL-15 superagonist N-803 with Abraxane in Merkel cell carcinoma: a case study. Journal for immunotherapy of cancer. 8 (2), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Drusbosky, L. et al. (2020). Complete response to avelumab and IL-15 superagonist N-803 with Abraxane in Merkel cell carcinoma: a case study. Journal for immunotherapy of cancer. 8 (2), p. . [Online].